University Hospitals’ Post

Do you remember having an infection that only got sorted with an antibiotic? You know the relief of getting better? 💪💊🛑 Without antibiotics, infections are mostly likely lethal or cause disability. 💊 Medical care depends on #antibiotics and antifungals working. Microorganisms adapt and evolve very fast (they have been here on Earth 🌎 for billions of years, so believe me, their genetic material keeps all the secrets of survival and adaptation). As a consequence, they have an incredible capacity to become resistant to one or multiple antibiotics. Pollution we caused in the environment has accelerated the speed at which microorganisms adapt. We basically created a super-duper environmental gym where they train their "genetic muscles" - allow me the analogy here - with the most amazing chemical mixtures, and in the environment we created, they learn much better how to survive and adapt. So, when they infect a person who has some sort of weakness, has undergone surgical treatment, or a newborn whose immune defenses are building up, you know what happens; in a matter of hours or days, the result is often very sad. We need to improve our environmental quality, infection control measures, rates of vaccinations, and definitely create incentives to fund, support, and give market resilience for the pharmaceutical industry to develop new antibiotics 🌐💉 Let me share with you a relevant event on #AMR. The event is going to be recorded. (https://lnkd.in/dUVWPdBK) 📆👀 Share, get informed. We all have a role to play in protecting our antibiotics. #WorldAMRAwarenessWeek2023 #AntibioticResistance #Healthcare #PublicHealth #InfectionControl

🎓Excited to Share that I have completed 1month"Antimicrobial Stewardship Course" from Stanford School of Medicine! 🎓 This comprehensive program has equipped me with invaluable skills and knowledge to address the critical challenges surrounding antimicrobial use and resistance in healthcare. Here are some of the key highlights from the course: 🔍 *Application of IDSA Guidelines*: Learned to effectively apply Infectious Diseases Society of America (IDSA) guidelines in the treatment of common infections such as acute rhino-sinusitis, cystitis, and acute bronchitis, ensuring optimal patient care and antibiotic stewardship. 📚 *Incorporation of Guidelines for Sepsis*: Mastered the incorporation of guidelines and standardized protocols for diagnosing and prescribing antibiotic therapy in the management of sepsis, a life-threatening condition where timely and appropriate treatment is crucial. 💡 *Development of Evidence-Based Practices*: Gained insights into developing and implementing evidence-based practices for antimicrobial stewardship within my practice setting, emphasizing the importance of rational antibiotic use and resistance prevention. I'm excited to leverage these skills and strategies to contribute effectively to antimicrobial stewardship efforts, optimize patient outcomes, and combat the global threat of antibiotic resistance. Let's work together to safeguard the future of healthcare! #AntimicrobialStewardship #StanfordMedicine #HealthcareLeadership

Thrilled to have immersed myself in the Medicines Management Symposium on Infectious Disease. 🌐💊 The symposium was a deep dive into the latest advancements in managing infectious diseases through effective medicines management strategies. From antimicrobial stewardship to personalized treatment approaches, every session was a wealth of knowledge. Engaging with experts and fellow attendees provided a rich platform for insightful discussions and knowledge exchange. The symposium not only broadened my understanding of infectious disease management but also underscored the critical role of collaborative efforts in combating global health challenges. Excited to integrate these learnings into my practice, contributing to the ongoing dialogue on optimizing patient outcomes in infectious disease scenarios. #MedicinesManagement #infectiousdiseases #HealthcareSymposium #professionaldevelopment

New publication within The Lancet Infectious Diseases: How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework. In 2021 the Italian Medicine Agency (AIFA Agenzia Italiana del farmaco), appointed a working group to support its main scientific committee to optimise the use of antibiotics in Italy. This article describes the process of the working group on the development of international evidence-based guidance documents on treating infections caused by multidrug resistant bacteria (MDB) by using the GRADE-ADOLOPMENT Framework methodology and integrating antibiotic stewardship principles. Click below to read more 🖱 👇 https://lnkd.in/dfYWEHCC

New study alert! Addressing the looming threat of antimicrobial resistance, rapid point-of-care tests for infection (POCTs) emerge as a promising solution to curb overprescribing. A new vignette-based study, led by @Suveer Singh and @Martine Nurek of Imperial College London, confirms that negative POCT results can significantly sway ICU doctors to stop antibiotic treatment. However, factors like the doctor’s perceived need for antibiotics and their interest in utilising POCTs also played an important role. 🌟 This study signposts important clinical, cognitive, and behavioural factors that influence antibiotic prescribing in ICU, paving the way for smarter, more effective healthcare strategies.  The full article has just been published in BMJ Open, find it here: WHY STOP? A prospective observational vignette-based study to determine the cognitive-behavioural effects of rapid diagnostic PCR-based point-of-care test results on antibiotic cessation in ICU infections  #AntibioticStewardship #HealthcareInnovation #POCTs #AntimicrobialResistance     

In Norway we are pleased that our most prescribed antibiotic for treating infections is penicillin v (phenoxymethylpenicillin), first marketed in the 1950s. The main indication for narrow-spectrum penicillins in primary care is respiratory tract infections. Therefore, we monitor penicillin-resistant pneumococci. As you can see from the graph showing the number of reported bacterial isolates with penicillin-resistant pneumococci in Norway from 2012 to 2023, the numbers remain very small. There was a small “peak” in 2016 (less than 30 isolates), and only six people with penicillin-resistant pneumococci in 2023. Older antibiotics like phenoxymethylpenicillin still work, and we need to maintain reliable access to them. Important for patients. Important for hindering antibiotic resistance #amr. I'm very pleased that in EU-JAMRAI we are working, in collaboration with our national and European colleagues, to strengthen access to critically important antibiotics like phenoxymethylpenicillin. Norwegian Institute of Public Health

I'm thrilled to share my experience of attending the International Society of Antimicrobial Chemotherapy (ISAC) Webinar on "One Health Aspects of #AMR & Infections in Asia" held on May 9, 2024. This certificate proudly certifies my participation in this enlightening event! The webinar was expertly organized by International Society of Antimicrobial Chemotherapy (ISAC) Academy, led by the esteemed Prof. Geoff Coombs, President of International Society of Antimicrobial Chemotherapy (ISAC), and Asia-Pacific Society of Clinical Microbiology and Infection (APSCMI). The topic of the webinar was timely and critical: "One Health Aspects of #AMR & Infections in Asia". The discussion revolved around the pressing issue of Antimicrobial Resistance (AMR) and its far-reaching consequences in the region. Here are the key points I took away from the webinar: 🔸️The importance of a "One Health" approach to address #AMR, recognizing the interconnectedness of human, animal, and environmental health. 🔸️The latest research and challenges in combating AMR in Asia. 🔸️Strategies for improving antimicrobial stewardship and infection prevention. 🔸️The need for collaboration, awareness, and education to tackle AMR. The webinar featured diverse perspectives from scientists, healthcare professionals, and industry experts, all united in their commitment to addressing the AMR crisis. The discussions emphasized the importance of collaboration, awareness, and education in tackling this global health threat. As I engaged with the webinar, I felt inspired by the wealth of knowledge shared and the dedication of the speakers. I left the webinar feeling empowered, equipped with new insights, and eager to contribute to the fight against AMR! #AMR #OneHealth #InfectionPrevention #AntimicrobialStewardship #GlobalHealth #ISACWebinar #APSCMI #GeoffCoombs #ISACPresident

2023: The year that was I’ve written, edited, proofread and project-managed more than a million words in 2023 across websites, articles, grants, reports, app content and books—but there have been three highlights, and here’s why: ⭐️ Interesting—project managing and editing AURA2023 allowed me to see the trends in bacterial and fungal infection resistances and antibiotic usage across Australia, and to communicate these widely. Our healthcare and aged care settings hold some of the most vulnerable members of our society. Knowledge is power: data and surveillance are the keys to preventing infection and having drugs that can effectively treat infection. 💡 Inspiring—writing case studies for a Sydney University/Deloitte project that measured the wider impacts of research required me to interview Professor Weiss, whose research fundamentally changes the current approaches to wound healing and treating tissue damage, such as after a heart attack. Interviewing him was just awe-inspiring. 🫶 Impactful—writing healthcare professional and consumer books for Indigenous Australians on maintaining a strong and healthy heart for the Heart Foundation. Coronary heart disease is Australia’s number one killer, taking 1 Australian life every 12 minutes. I hope that these resources will help prevent this potentially silent killer. 🥂Here's to a healthy, meaningful and peaceful 2024.

هل استخدام المضادات الحيوية لمدة قصيرة ام طويلة افضل و احسن فاعلية ⏳ Must read #ShorterVsLonger antibiotic duration fron this article “‏Shorter and Longer Antibiotic Durations for Respiratory Infections: To Fight Antimicrobial Resistance—A Retrospective Cross-Sectional Study in a Secondary Care Setting in the UK” https://lnkd.in/dHVQYW6D #antibiotics #ResearchGate

هل استخدام المضادات الحيوية لمدة قصيرة ام طويلة افضل و احسن فاعلية ⏳ Must read #ShorterVsLonger antibiotic duration fron this article “‏Shorter and Longer Antibiotic Durations for Respiratory Infections: To Fight Antimicrobial Resistance—A Retrospective Cross-Sectional Study in a Secondary Care Setting in the UK” https://lnkd.in/dHVQYW6D #antibiotics #ResearchGate